Consistent with data previously reported on GBM stabilized cells, iPA treatment (at 10 μM) induced the activation of necroptosis markers RIP1, RIP3, and MLKL, and the increase of protein levels of HMGB1 and PUMA in GBM1 cells (Fig. 6F). This evidence concerns the gene RIPK3 and glioblastoma.